Quotes 5-day view End-of-day quote Shenzhen Stock Exchange
11/27/2020
11/30/2020
12/01/2020
12/02/2020
12/03/2020
Date
90.7
91.29
92.29
92.38
97.17
Last
3528085
3409118
3802176
3298917
7583152
Volume
-1.07% +0.65% +1.10% +0.10% +5.19% Change
Sales 2020
1 954 M 299 M 299 M
Net income 2020
470 M 71,9 M 71,9 M
Net Debt 2020
849 M 130 M 130 M
P/E ratio 2020
96,4x
Yield 2020
0,27%
Sales 2021
2 693 M 412 M 412 M
Net income 2021
467 M 71,4 M 71,4 M
Net Debt 2021
1 059 M 162 M 162 M
P/E ratio 2021
87,5x
Yield 2021
0,32%
Capitalization
39 162 M 5 986 M 5 992 M
EV / Sales 2020
20,5x
EV / Sales 2021
14,9x
Nbr of Employees
1 328
Free-Float
100%
Betta Pharmaceuticals Co., Ltd. is a China-based company principally engaged in the research and development, manufacturing, sales and marketing of drugs to treat malignant tumors, diabetes, cardiovascular and cerebrovascular diseases. The Company’s core product is icotinib, which is a kind of antineoplastic agent. Its products also include burn pain relieving plaster, oryzanol vitamin B1 and vitamin B6 tablets....
Notations Surperformance© of Betta Pharmaceuticals Co., Ltd.
Trading Rating : Investor Rating :
All news about BETTA PHARMACEUTICALS CO., LTD.
- No features available -
News in other languages on BETTA PHARMACEUTICALS CO., LTD.
- No features available -
Chart BETTA PHARMACEUTICALS CO., LTD.
Duration :
Auto.
2 months
3 months
6 months
9 months
1 year
2 years
5 years
10 years
Max.
Period :
Day
Week
Technical analysis trends BETTA PHARMACEUTICALS CO., LTD.
Short Term Mid-Term Long Term Trends Bearish Bearish Neutral
Income Statement Evolution
Please enable JavaScript in your browser's settings to use dynamic charts.
Mean consensus
BUY
Number of Analysts
8
Average target price
80,22 CNY
Last Close Price
97,17 CNY
Spread / Highest target
-10,5%
Spread / Average Target
-17,4%
Spread / Lowest Target
-24,4%
Please enable JavaScript in your browser's settings to use dynamic charts.
Canada
Deutschland
France
Schweiz (DE)
United Kingdom
Report
